PG
WST icon

Pendal Group’s West Pharmaceutical WST Stock Holding History

Pendal Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,656
Closed -$252K – 521
2020
Q1 		$252K Sell
1,656
-547
-25% -$84.2K ﹤0.01% 326
2019
Q4 		$331K Sell
2,203
-387
-15% -$56.3K ﹤0.01% 350
2019
Q3 		$367K Sell
2,590
-205
-7% -$28.2K ﹤0.01% 385
2019
Q2 		$350K Sell
2,795
-156
-5% -$18.4K ﹤0.01% 372
2019
Q1 		$325K Buy
2,951
+983
+50% +$102K ﹤0.01% 390
2018
Q4 		$193K Buy
1,968
+505
+35% +$54.8K ﹤0.01% 389
2018
Q3 		$181K Buy
+1,463
New +$164K ﹤0.01% 418

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Pendal Group's WST Position: Q2 2020 in Review

Pendal Group sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 1,656 shares — an estimated $252K sold.

Pendal Group first reported a position in WST in Q3 2018 and held it in 7 quarters. The position peaked at $367K in Q3 2019. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Pendal Group reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Pendal Group sold 1,656 West Pharmaceutical shares in Q2 2020, an estimated $252K.
  • Pendal Group first reported a position in West Pharmaceutical in Q3 2018 and held it in 7 quarters.
  • Pendal Group's West Pharmaceutical position peaked at $367K in Q3 2019.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Pendal Group's 13F filing for Q2 2020, filed 7 Aug 2020.